Literature DB >> 15517139

[PET/CT for colorectal and hepatic tumors].

J Stollfuss1, H Wieder, E Rummeny, M Schwaiger.   

Abstract

This contribution presents clinical and technical aspects of combining positron emission tomography (PET) and computed tomography (CT) for patients with colorectal tumors and characterization of unclear liver foci. In which manner and for which patients combined PET/CT is superior to PET or CT alone is also discussed. PET/CT can fulfil most prerequisites for imaging in pre- and postoperative management of patients with colorectal tumors and best meets the desire for optimal imaging procedures. Some of the disadvantages encountered in frequently employed CT can be overcome by the combination of PET and CT while increasing both sensitivity in detecting lesions and specificity in their characterization. Questions regarding treatment response offer an opportunity for devising novel study concepts and initiating research on new PET tracers. Although few publications are available, we are of the opinion that the combination of functional and anatomical imaging provided by PET/CT can improve both preoperative management and aftercare. To this end, however, optimum cooperation between practitioners of nuclear medicine and radiology is imperative.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517139     DOI: 10.1007/s00117-004-1123-8

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  87 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

3.  Recurrence of colorectal tumors: PET evaluation.

Authors:  L G Strauss; J H Clorius; P Schlag; B Lehner; B Kimmig; R Engenhart; M Marin-Grez; F Helus; F Oberdorfer; P Schmidlin
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

Review 4.  Hereditary benign and malignant lesions of the large bowel.

Authors:  J Wennstrom; E R Pierce; V A McKusick
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

5.  Combined PET/CT Imaging in Oncology. Impact on Patient Management.

Authors:  P G. Kluetz; C C. Meltzer; V L. Villemagne; P E. Kinahan; S Chander; M A. Martinelli; D W. Townsend
Journal:  Clin Positron Imaging       Date:  2000-11

6.  Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques.

Authors:  R C Semelka; S Worawattanakul; N L Kelekis; G John; J T Woosley; M Graham; W G Cance
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

Review 7.  Chemoradiotherapy for rectal cancer--is there an optimal combination?

Authors:  B Glimelius
Journal:  Ann Oncol       Date:  2001-08       Impact factor: 32.976

8.  Screening for colorectal cancer in a Hungarian county.

Authors:  L Ujszászy; G Prónay; G Nagy; J Kovács; J Libor; K Minik
Journal:  Endoscopy       Date:  1985-05       Impact factor: 10.093

9.  In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.

Authors:  K Higashi; A C Clavo; R L Wahl
Journal:  J Nucl Med       Date:  1993-05       Impact factor: 10.057

10.  Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.

Authors:  Jose G Guillem; Harvey G Moore; Timothy Akhurst; David S Klimstra; Leyo Ruo; Madhu Mazumdar; Bruce D Minsky; Leonard Saltz; W Douglas Wong; Steven Larson
Journal:  J Am Coll Surg       Date:  2004-07       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.